May 3 |
Amgen shares soar as executives outline obesity drug push
|
May 3 |
US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited
|
May 3 |
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
|
May 3 |
Eli Lilly: Don't Overpay For Miracle Drugs
|
May 2 |
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
|
May 2 |
Analysts reveal Eli Lilly stock price targets after earnings
|
May 2 |
Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
|
May 2 |
Amgen Soars After CEO Gives Update on Experimental Obesity Drug
|
May 2 |
Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
|
May 2 |
Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
|